Onselex Pharmaceuticals

Successfully developed a non-toxic, highly effective anti-cancer nanomedicine. Reduce the pancreatic cancer death rate by 70%, with minimal/no side effects.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location New York, NY, USA
  • Currency USD
  • Founded August 2018
  • Employees 1
  • Incorporation Type C-corp
  • Website onselex.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free